Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human PLAU Polyclonal Antibody

Catalog #:   PHB88301 Specific References (27) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P00749
Overview

Catalog No.

PHB88301

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human PLAU (Thr186-Leu431).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

PLAU, uPA, U-plasminogen activator, Urokinase-type plasminogen activator

Purification

Purified by antigen affinity column.

Accession

P00749

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN-BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with PLAU antibody (PHB88301) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 30 kDa
    Observed MW: 30 kDa
  • Western Blot
    Various lysates were subjected to SDS PAGE followed by western blot with PLAU antibody (PHB88301) at 1 μg/ml.

    Lane 1: MCF7

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 49 kDa
    Observed MW: 49 kDa
  • Immunohistochemical
    Immunohistochemical analysis of human colon tissue stained for PLAU with PHB88301.
References

[Efficient capture and proteomics analysis of urinary extracellular vesicles by affinity purification]., PMID:40331614

PLAU promotes growth and attenuates cisplatin chemosensitivity in ARID1A-depleted non-small cell lung cancer through interaction with TM4SF1., PMID:38229120

PLAU and LAMC2 can predict a poor prognosis in patients with HNSCC., PMID:37325056

Urokinase Plasminogen Activator Deficiency Aggravates Cationic Bovine Serum Albumin-Induced Membranous Nephropathy Through T Helper Cell Type 2-Prone Immune Response in Mice., PMID:37004912

Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors., PMID:36510222

A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer., PMID:34215253

Engineered Antibody Fragment against the Urokinase Plasminogen Activator for Fast Delineation of Triple-Negative Breast Cancer by Positron Emission Tomography., PMID:33734721

The cAMP-ERK1/2 signaling pathway regulates urokinase-type plasminogen activator-induced bovine granulosa cell proliferation., PMID:33112787

Crucial Involvement of IL-6 in Thrombus Resolution in Mice via Macrophage Recruitment and the Induction of Proteolytic Enzymes., PMID:32117207

Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer., PMID:31904863

DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression., PMID:30660488

The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets., PMID:30516104

Contribution of the TNF-α (Tumor Necrosis Factor-α)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus., PMID:30354252

Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts., PMID:29760157

Immune cell and transcriptomic analysis of the human decidua in term and preterm parturition., PMID:28962035

Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy., PMID:28681388

Hyperglycemia-suppressed expression of Serpine1 contributes to delayed epithelial wound healing in diabetic mouse corneas., PMID:26024123

Imaging active urokinase plasminogen activator in prostate cancer., PMID:25672980

Involvement of the serine protease inhibitor, SERPINE2, and the urokinase plasminogen activator in cumulus expansion and oocyte maturation., PMID:24023701

Fasting reduces liver fibrosis in a mouse model for chronic cholangiopathies., PMID:23707514

D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo., PMID:21654676

Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9., PMID:21075828

Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation., PMID:20466854

Administration of betaHCG leads to dose-dependent changes of gene expression signature of endometriotic stromal cells., PMID:20395176

Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence., PMID:18584856

Bovine colostrum in oral treatment of enterogenic endotoxaemia in rats., PMID:12493077

Plaunotol suppresses interleukin-8 secretion induced by Helicobacter pylori: therapeutic effect of plaunotol on H. pylori infection., PMID:10824880

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human PLAU Polyclonal Antibody [PHB88301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only